Validation of RCC Predicting Model With Emulated-target Trial
NCT07117227 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4700
Last updated 2026-04-14
Summary
This single-center study utilizes real-world data (2012-2024) from 4700 renal cell carcinoma (RCC) patients at Peking University Third Hospital to: (1) Develop and validate a prognostic prediction model specifically for RCC patients, including those with venous tumor thrombus (VTT); (2) Compare the performance of this new model against existing RCC prediction models in both the overall RCC cohort and the VTT subgroup; (3) Employ an emulated target trial (ETT) methodology to evaluate whether risk-stratified treatment based on the prediction model (grouping patients as high/medium/low risk) improves survival outcomes .
Conditions
- Renal Cell Carcinoma (Kidney Cancer)
- Renal Cell Carcinoma (RCC)
- Tumor Thrombus
- Prognosis
- Prognostic Cancer Model
- Real World Study
- Observational Study
Interventions
- PROCEDURE
-
Model-guided adjuvant treatment
Initiation of standard adjuvant treatment within 12 weeks after surgery.
- PROCEDURE
-
No adjuvant treatment
No initiation of adjuvant ICIs, radiotherapy, or targeted therapy at any point during follow-up prior to disease progression.
Sponsors & Collaborators
-
Peking University Third Hospital
lead OTHER
Principal Investigators
-
Yongyue Wei, master · Peking University Health Science Center
-
Shudong Zhang, master · Peking University Third Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2027-02-01
- Completion
- 2027-08-01
Countries
- China
Study Locations
More Related Trials
-
Preoperative Intraarterial Chemoembolization Combined With Radiotherpy in Locally Advanced Rectal Cancer
NCT03601156 ·Status: UNKNOWN ·Phase: NA
-
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
NCT04755907 ·Status: UNKNOWN
-
GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer.
NCT05674422 ·Status: ACTIVE_NOT_RECRUITING
-
Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer
NCT03615170 ·Status: UNKNOWN
-
Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
NCT06531629 ·Status: COMPLETED
-
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk
NCT04664504 ·Status: RECRUITING ·Phase: PHASE2
-
Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC
NCT03156036 ·Status: COMPLETED ·Phase: PHASE2
-
Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors
NCT03177382 ·Status: UNKNOWN ·Phase: PHASE3
-
Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies
NCT07014254 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Development and Validation of a PSN-AI Prediction Model
NCT06231524 ·Status: RECRUITING
-
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer
NCT04287400 ·Status: RECRUITING
-
Prospectively Predict the Efficacy and Explore the Mechanism of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy
NCT05427227 ·Status: UNKNOWN
-
Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM
NCT03125161 ·Status: UNKNOWN ·Phase: PHASE3
-
Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer
NCT07034742 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.
NCT06613269 ·Status: RECRUITING ·Phase: PHASE2
-
New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases
NCT01307878 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Sequential Therapy in Locally Advanced Mid/Low Rectal Cancer
NCT02022852 ·Status: UNKNOWN ·Phase: PHASE2
-
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer
NCT06293612 ·Status: COMPLETED
-
Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal Tumors
NCT06908902 ·Status: RECRUITING ·Phase: NA
-
The Implication of ctDNA in the Recurrence Surveillance of Stage II and III Colorectal Cancer
NCT03416478 ·Status: UNKNOWN
-
High Dose Rate Interstitial Brachytherapy With Three Dimensional Printing Template for Recurrent Gynecologic Tumors
NCT04127435 ·Status: UNKNOWN
-
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
NCT06088134 ·Status: RECRUITING
-
Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer
NCT07209384 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer
NCT07349043 ·Status: RECRUITING ·Phase: PHASE1